Non-amyloid Fibrillary Glomerulopathy (FGN and ITG): A Patient Guide

Non-amyloid fibrillary glomerulopathies, including Fibrillary Glomerulonephritis (FGN) and Immunotactoid Glomerulopathy (ITG), are exceptionally rare conditions where abnormal proteins clump together and get stuck in the glomeruli, the tiny filters of your kidneys. While they share similar names, they are distinguished by how these proteins look under a high-powered electron microscope: FGN is typically characterized by solid, randomly tangled threads called fibrils, whereas ITG usually involves larger, hollow, and often neatly organized tubes known as microtubules ^[1][2]. Because these deposits physically crowd and damage the filters, they cause the kidneys to leak protein into the urine and lose their ability to clean the blood effectively over time ^[3].

Getting an accurate diagnosis is the most critical first step, as these diseases can mimic more common conditions like amyloidosis. Pathologists use specialized stains and tests together to make a diagnosis. For example, the DNAJB9 stain acts as a strong “fingerprint” supporting FGN, and the Congo Red stain is a key screening tool that is typically negative in FGN and ITG (unlike amyloidosis) ^[4][5]. Distinguishing between FGN and ITG is equally vital because they often point to different causes elsewhere in the body. FGN is typically a standalone immune issue or linked to general inflammation, while ITG is strongly associated with underlying blood conditions, such as Chronic Lymphocytic Leukemia (CLL) or other “clones” of abnormal immune cells ^[6][7].

Treatment is highly personalized and focuses on both protecting the kidneys and addressing the source of the abnormal proteins. When clinically appropriate, “supportive care” using blood pressure medications like ACE inhibitors or ARBs is the foundation of treatment to reduce the strain on the kidney filters ^[8]. Beyond this, therapy diverges depending on your specific situation: FGN may sometimes be treated with immune-dampening drugs like Rituximab, whereas ITG treatment often targets the specific blood clone or underlying disorder if one is identified during your workup ^[9][1]. Because these are rare diseases, your care team will often involve both a kidney specialist (nephrologist) and a blood specialist (hematologist) to ensure all aspects of the condition are addressed.

Living with FGN or ITG means managing a chronic condition that requires long-term, individualized monitoring of your blood pressure, urine protein, and kidney function. While population statistics show that these conditions can progress to kidney failure over time, modern medicine offers several paths forward, including dialysis and kidney transplantation ^[10]. Although the disease can sometimes return in a transplanted kidney, many people continue to lead full lives with a transplant for many years ^[11]. By working closely with your specialists and staying informed about your biopsy results and lab trends, you can take an active role in navigating this rare diagnosis with confidence.